Overprescription of short-acting β<sub>2</sub>-agonists is associated with poor asthma symptom control: results from five Middle Eastern countries included in the SABINA International (III) studyAshraf Al Zaabi, Maarten Beekman, Kurtuluş Aksu et al.|Expert Review of Respiratory Medicine|2022Cited by 15
Overprescription of short-acting β<sub>2</sub>-agonists is associated with poor asthma symptom control: results from five Middle Eastern countries included in the SABINA International (III) studyAshraf Al Zaabi, Maarten Beekman, Nasser Al Busaidi et al.|Figshare|2022Cited by 0